anti-CD11a (hu1124): Began Phase III trial

By WIR Staff | Jan 4, 2000 | 8:00 AM GMT

Genentech Inc. (DNA), South San Francisco,

Read the full 63 word article

How to gain access

Continue reading with a
two-week free trial.